+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Topoisomerase II is required for mitoxantrone to signal nuclear factor kB activation in HL60 cells



Topoisomerase II is required for mitoxantrone to signal nuclear factor kB activation in HL60 cells



The Journal of Biological Chemistry 275(33): 231-8




(PDF emailed within 1 workday: $29.90)

Accession: 018187216

Download citation: RISBibTeXText


Related references

Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells. Journal of Biological Chemistry 275(33): 25231-8, 2000

Protein kinases negatively affect nuclear factor-kB activation by tumor necrosis factor-a at two different stages in promyelocytic HL60 cells. The Journal of Biological Chemistry 267: 65-72, 1992

Intact Ras function is required for sustained activation and nuclear translocation of extracellular signal-regulated kinases in nerve growth factor-stimulated PC12 cells. European Journal of Cell Biology 75(1): 54-58, 1998

Protein kinases negatively affect nuclear factor-kappa B activation by tumor necrosis factor-alpha at two different stages in promyelocytic HL60 cells. Journal of Biological Chemistry 267(3): 2065-2072, 1992

Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II b isoform. Biochemistry (American Chemical Society) 30: 53-61, 1991

Mitoxantrone resistance in hl 60 leukemia cells reduced nuclear topoisomerase ii catalytic activity and drug induced dna cleavage in association with reduced expression of the topoisomerase ii beta isoform. Biochemistry 30(41): 9953-9961, 1991

Presence of a beta-II protein kinase C-specific nuclear activation factor in HL60 cell nuclear envelopes. Journal of Cellular Biochemistry Supplement 0(18D): 86, 1994

Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. Journal of Pharmacology and Experimental Therapeutics 316(1): 71-78, 2005

The activation and nuclear translocation of extracellular signal-regulated kinases (ERK-1 and -2) appear not to be required for elongation of neurites in PC12D cells. Brain Research 688(1-2): 213-218, 1995

Activation of the MAP kinase signal transduction pathway is required for proliferation of factor-dependent MO7E cells, but not for factor-independent Dami and Meg-01 megakaryocytic cell lines. Blood 88(10 SUPPL 1 PART 1-2): 58A, 1996

Nuclear factor Y is required for basal activation and chromatin accessibility of fibroblast growth factor receptor 2 promoter in osteoblast-like cells. Journal of Biological Chemistry 284(5): 3136-3147, 2008

Persistent activation of both extracellular signal-regulated protein kinases and nuclear factor-kappaB is required for induction of nitric oxide synthase by interleukin-1beta. Hypertension 36(4): 719, 2000

Nerve growth factor activation of nuclear factor kB through its p75 receptor is an anti-apoptotic signal in RN22 schwannoma cells. The Journal of Biological Chemistry 275(11): 58-65, 2000

Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells. European Journal of Pharmacology 721(1-3): 141-150, 2014

Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase. Implications for increasing its ability to inhibit the growth of sensitive and multidrug resistant leukaemia HL60 cells. Cancer Letters 245(1-2): 252-262, 2006